Americas (WHO region) vs Viet Nam: Cases started on MDR-TB treatment
Americas (WHO region)
5,225
in 2024
Viet Nam
3,050
in 2024
Americas (WHO region) rank
11th
Viet Nam rank
11th
Cases started on MDR-TB treatment over time
- Americas (WHO region)
- Viet Nam
How they compare
Americas (WHO region) currently reports 5,225 against 3,050 in Viet Nam, a difference of 2,175.
That makes Americas (WHO region)'s figure about 1.7 times Viet Nam's.
Across all 16 years both countries report, Americas (WHO region) has been ahead every year.
Americas (WHO region) ranks 11th and Viet Nam ranks 11th of 11 groups.
Americas (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,161 | 307 | 2,854 | Americas (WHO region) |
| 2010s | 3,609 | 1,707 | 1,901 | Americas (WHO region) |
| 2020s | 4,846 | 3,179 | 1,668 | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Americas (WHO region) or Viet Nam?
- Americas (WHO region), at 5,225 against 3,050 in Viet Nam as of 2024.
- What is the difference in cases started on mdr-tb treatment between Americas (WHO region) and Viet Nam?
- 2,175, with Americas (WHO region) ahead.
- How many years of comparable data are there for Americas (WHO region) and Viet Nam?
- 16 years are reported by both, from 2009 to 2024.
- How do Americas (WHO region) and Viet Nam rank globally for cases started on mdr-tb treatment?
- Americas (WHO region) ranks 11th and Viet Nam ranks 11th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.